SP
Sivasankara Pillai Nandakumar
About Sivasankara Pillai Nandakumar
Data last updated:
Sivasankara Pillai Nandakumar has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Munus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Munus Pharmaceuticals Private Limited at ₹3.61 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Munus Pharmaceuticals Private Limited U24304KL2016PTC047341 | Director | 23 Nov 2016 | 2016 | ₹3.61 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sivasankara Pillai Nandakumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sivasankara Pillai Nandakumar
Sivasankara Pillai Nandakumar has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Munus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Munus Pharmaceuticals Private Limited at ₹3.61 Cr (FY 2025).
Sivasankara Pillai Nandakumar is associated with 1 company as Director, including Munus Pharmaceuticals Private Limited (₹3.61 Cr).
Sivasankara Pillai Nandakumar has expertise in General Business.
Sivasankara Pillai Nandakumar has 9 years in corporate governance.
By reported revenue, the largest current company of Sivasankara Pillai Nandakumar is Munus Pharmaceuticals Private Limited, with revenue of ₹3.61 Cr (FY 2025).
Sivasankara Pillai Nandakumar currently holds positions at 1 company: Munus Pharmaceuticals Private Limited (₹3.61 Cr).